Skip to main content

Peer Review reports

From: Efficacy and safety of combined immunotherapy and antiangiogenic therapy for advanced non-small cell lung cancer: a real-world observation study

Original Submission
2 Nov 2022 Submitted Original manuscript
22 Jan 2023 Reviewed Reviewer Report
21 Feb 2023 Reviewed Reviewer Report
6 Mar 2023 Author responded Author comments - Xingya Li
8 Mar 2023 Author responded Author comments - Xingya Li
Resubmission - Version 2
6 Mar 2023 Submitted Manuscript version 2
14 Mar 2023 Reviewed Reviewer Report
29 Mar 2023 Reviewed Reviewer Report
5 Apr 2023 Author responded Author comments - Xingya Li
Resubmission - Version 3
5 Apr 2023 Submitted Manuscript version 3
17 Apr 2023 Reviewed Reviewer Report
21 Apr 2023 Reviewed Reviewer Report
2 May 2023 Author responded Author comments - Xingya Li
Resubmission - Version 4
2 May 2023 Submitted Manuscript version 4
Publishing
4 May 2023 Editorially accepted
19 May 2023 Article published 10.1186/s12890-023-02470-z

You can find further information about peer review here.

Back to article page